Urticaria News and Research

RSS
Urticaria are itchy, raised red areas on the skin. Urticaria are caused by a reaction to certain foods, drugs, infections, or emotional stress. Also called hives.
New approach to cultivate hypoallergenic tomato and strawberry varieties

New approach to cultivate hypoallergenic tomato and strawberry varieties

New results reinforce COPAXONE 40 mg/mL as safe and effective for RMS patients

New results reinforce COPAXONE 40 mg/mL as safe and effective for RMS patients

Acid-suppressing medicines and antibiotics in infancy linked to later allergic disease risk

Acid-suppressing medicines and antibiotics in infancy linked to later allergic disease risk

AstraZeneca’s new precision biologic gets FDA approval to treat severe eosinophilic asthma

AstraZeneca’s new precision biologic gets FDA approval to treat severe eosinophilic asthma

ACADIA Pharmaceuticals announces results from Phase II study of antipsychotic in Alzheimer's disease psychosis

ACADIA Pharmaceuticals announces results from Phase II study of antipsychotic in Alzheimer's disease psychosis

First-ever treatment for Merkel cell carcinoma receives approval in Japan

First-ever treatment for Merkel cell carcinoma receives approval in Japan

FDA grants accelerated approval to new treatment for children with Chagas disease

FDA grants accelerated approval to new treatment for children with Chagas disease

Many chronic urticaria patients are not receiving treatment, Novartis study shows

Many chronic urticaria patients are not receiving treatment, Novartis study shows

Steroids offer no additional relief to emergency patients suffering from hives

Steroids offer no additional relief to emergency patients suffering from hives

Patients with inducible urticaria can benefit from treatment with asthma drug

Patients with inducible urticaria can benefit from treatment with asthma drug

‘The Agony of Hives’: WAO to offer complementary live webinar on chronic urticaria

‘The Agony of Hives’: WAO to offer complementary live webinar on chronic urticaria

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

Contact dermatitis or contact eczema?

Contact dermatitis or contact eczema?

Penicillin allergy testing: an interview with Dr. Eric Macy

Penicillin allergy testing: an interview with Dr. Eric Macy

TARGET My Hives app for people impacted by chronic urticaria now available in Android, iOS systems

TARGET My Hives app for people impacted by chronic urticaria now available in Android, iOS systems

Baxalta seeks FDA approval for ADYNOVATE to treat children with hemophilia A and for use in surgical settings

Baxalta seeks FDA approval for ADYNOVATE to treat children with hemophilia A and for use in surgical settings

Romosozumab for postmenopausal women with osteoporosis meets co-primary endpoints in Phase 3 study

Romosozumab for postmenopausal women with osteoporosis meets co-primary endpoints in Phase 3 study

Iroko announces availability of VIVLODEX capsules in U.S. pharmacies for patients with OA pain

Iroko announces availability of VIVLODEX capsules in U.S. pharmacies for patients with OA pain

NIH researchers identify genetic mutation responsible for vibratory urticaria

NIH researchers identify genetic mutation responsible for vibratory urticaria

Amgen announces approval of cholesterol-lowering medication Repatha (evolocumab) Injection in Japan

Amgen announces approval of cholesterol-lowering medication Repatha (evolocumab) Injection in Japan